Myriad Genetics reported $119.5M in Gross Profit on Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Agilent A:US $ 900M 48M
Becton, Dickinson and BDX:US $ 2254M 93M
Bio Rad Laboratories BIO:US $ 441.56M 38.86M
Biocept BIOC:US $ 7.18M 2.59M
Bruker BRKR:US $ 308.7M 28.1M
Danaher DHR:US $ 4359M 38M
Exact Sciences EXAS:US $ 340.64M 19.79M
Fluidigm FLDM:US 13.67M 2.75M
Genmark Diagnostics GNMK:US $ 19.4M 2.86M
Hologic HOLX:US $ 828.1M 126.5M
Illumina ILMN:US $ 770M 32M
Johnson & Johnson JNJ:US $ 16088M 343M
Luminex LMNX:US $ 66.46M 2.02M
Mettler Toledo International MTD:US 555.82M 18.92M
Myriad Genetics MYGN:US $ 119.5M 16.2M
Orasure Technologies OSUR:US $ 21.47M 9.2M
Oxford Immunotec Global OXFD:US $ 14.86M 11.19M
Pacific Biosciences Of California PACB:US $ 15.36M 1.61M
Perkinelmer PKI:US $ 631.84M 53.36M
Quest Diagnostics DGX:US $ 1111M 114M
Quidel QDEL:US $ 373.41M 267.22M
Repligen RGEN:US $ 102.72M 1.75M
Thermo Fisher Scientific TMO:US $ 4797M 273M
Veracyte VCYT:US $ 38.73M 1.09M
Waters WAT:US $ 388.1M 13.29M